The SLC22A16 gene gives cells instructions for a transporter that moves carnitine, a nutrient that helps turn fat into energy, and some medicines across cell membranes. If it does not work well, some cells may handle energy less efficiently and may take up certain drugs differently. This gene plays an important role in how the body handles carnitine, especially in tissues such as the testes. It is also studied for how it may affect response to the chemotherapy drug doxorubicin.
What is a gene?
Genes are stretches of DNA that hold instructions cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly guide when specific processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medications. For a deeper look at this subject, you can find more in the LearnHub.
Overview
SLC22A16Gene function
What if the gene works
The SLC22A16 gene helps cells move carnitine, a nutrient used to turn fat into energy. This transport supports normal cell metabolism and energy use in some tissues.
Risk
What if the gene does not work
Changes in the SLC22A16 gene can range from milder to more severe and may reduce how well cells move certain charged molecules, including carnitine, across cell membranes. This can alter transport activity inside the cell.
Treatment
What does that mean for your treatment
No SLC22A16-specific treatment or management approach is currently established in clinical guidelines. The SLC22A16 gene is being studied as a transporter that may affect uptake of some cancer drugs, including doxorubicin, but this has not changed routine drug choice.
Gene function
What if the gene works
Your cells rely on the SLC22A16 gene to move certain small molecules across the cell membrane. One of its main jobs is bringing in carnitine, a compound that helps cells use fat for energy. This is a big part of what the SLC22A16 gene does in day to day cell fuel handling.
The SLC22A16 gene makes a transporter in the cell membrane that brings carnitine into cells. Carnitine helps move fatty acids into mitochondria, where cells can turn fat into energy.
By helping cells take in carnitine, this gene supports normal energy production from fat. This steady supply helps cells meet routine energy needs during everyday activity.
Its transporter also carries some other small positively charged molecules across the cell membrane. This helps cells manage the flow of selected compounds between the inside of the cell and its surroundings.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help create normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effects and simply represent natural genetic variation. In some cases, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC22A16 gene can change the transporter’s shape, stability, or delivery to the cell surface, which helps explain how SLC22A16 gene variants affect transporter activity. Milder variants may only partly reduce movement of carnitine or other charged molecules across the cell membrane. More severe variants can sharply lower protein levels, disrupt binding, or keep the transporter from working at all.
How variants are linked to conditions
At this stage, the SLC22A16 gene does not have a broadly confirmed link to one specific health condition, although research on how SLC22A16 variants are linked to conditions is still evolving. If you have a variant in the SLC22A16 gene, your doctor or genetic counselor can interpret it alongside your symptoms, family history, and test results.
A variant is not necessarily a diagnosis
Variants in genes are a routine feature of human biology and are widespread across the general population. Most do not directly affect health and simply contribute to normal human diversity. For many genes, having a variant tied to a condition points to a possible link rather than a clear diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLC22A16 gene. If a test shows a change in SLC22A16, a doctor or genetic counselor can help explain what it may mean in the context of your personal and family history.
Inheritance of SLC22A16 variants
There is not yet a broadly confirmed Mendelian inheritance pattern tied to a specific SLC22A16-related condition, so how are variants of the SLC22A16 gene inherited is still an evolving question in medical genetics. The SLC22A16 gene sits on chromosome 6, which is an autosome rather than a sex chromosome. That means you inherit one copy of the SLC22A16 gene from your mother and one copy from your father. As research develops, doctors may learn more about whether certain SLC22A16 gene changes follow a clear inherited pattern in families.
What does my SLC22A16 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific condition for the SLC22A16 gene, though this understanding can change as research develops. If you have a specific SLC22A16 result and questions about what it could mean for your family, a doctor or genetic counselor can help explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the SLC22A16 gene uses a blood or saliva sample to read this gene's DNA sequence. SLC22A16 genetic testing is usually done as part of a multigene panel or broader sequencing test, and the lab report groups any variant by its likely effect on health.
When should I consider getting a genetic test?
There is not yet a broadly established, SLC22A16-specific reason for routine genetic testing. Testing decisions are usually based on your personal health, family history, and the reason testing is being considered with a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic results can be informative, yet how much they explain varies by the condition and the specific variant. Over time, the way your body functions is also shaped by factors such as age, environment, lifestyle, and medical history. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. For medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same drug at the same dose, yet one may get better benefit while the other may notice less effect or more side effects. This happens in part because inherited differences can change how the body absorbs, moves, and clears a medication, which is a common reason treatment response varies from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way people respond to medications. It studies gene drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support more informed, more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the SLC22A16 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choices, so concerns about side effects, new symptoms, or how a treatment is working are best discussed with your doctor. SLC22A16 has been studied for how the body handles some chemotherapy medicines, especially doxorubicin, but this is not part of routine care.
History
In the early 2000s, researchers identified the SLC22A16 gene while mapping members of the solute carrier family, a large group of genes involved in moving substances into and out of cells. Initially understood only through visible traits, later recognized as tied to a specific gene, this area of research grew as scientists compared related transport genes across tissues. From these first observations, research expanded steadily, especially in studies of carnitine handling and the way some cancer medicines enter cells. Interest in the SLC22A16 gene also increased when laboratory work suggested it might influence response to certain chemotherapy drugs. Over time, descriptions became more precise as genetic and cell studies clarified where this gene is active and why it drew attention in cancer research.